Monopoly ETF (MPLY)

The Monopoly ETF (ticker MPLY) is a concentrated US equity fund that selects companies with such strong competitive advantages and market positions that they function as quasi-monopolies in their fields.

The thesis is straightforward. Monopolies and near-monopolies are rare in modern economies—antitrust law makes outright monopoly illegal, and most industries have competitors. But certain companies have built such wide competitive moats, such strong network effects, such sticky customer relationships, or such dominant cost positions that they operate with monopoly-like pricing power and profitability. The fund holds those companies.

What makes a moat monopoly-like. An ordinary competitive advantage (better product design, clever marketing) can be matched in a few years. A true monopoly moat is durable for a decade or more. Network effects are powerful here—the more users a platform has, the more valuable it becomes, and the harder it is to switch to a rival. Financial data providers, operating systems, exchanges, payment networks, and social platforms all benefit from network effects. So do marketplaces where liquidity concentrates: ride-hailing is hard to compete in because drivers cluster on the largest platform, and passengers follow drivers. Brand power also counts—a brand so strong and so loved that customers prefer it at a premium price and stay loyal across decades. And switching costs: enterprise software, medical devices, industrial-control systems, and other deep integrations into a customer’s operations carry such high switching costs that rivals have trouble dislodging incumbents.

The portfolio is lean. MPLY holds roughly 30 to 50 stocks, concentrated enough that any single holding typically represents 2 to 4 percent of the fund’s value. A concentrated portfolio of monopoly-scale companies is more volatile than a broad index, but the managers’ thesis is that the width of the moats and the quality of the companies justify that concentration. Sector bias is toward technology (software platforms, marketplaces, semiconductors), healthcare (pharmaceutical patents, medical devices, diagnostics), and consumer staples (brands with pricing power). Financial services companies with entrenched positions also appear.

Turnover is low. The fund holds positions for years if the monopoly-like position is intact, which lowers costs and tax drag. When a company’s competitive advantage erodes—a new rival emerges, regulations shift, technology disrupts the business model—the fund exits. But the base assumption is that true moats persist, so holding periods are measured in years, not months.

Dividends and free cash flow matter. Monopoly-like companies typically generate enormous free cash flow because their profits do not disappear into competitive spending battles. Many use that cash to pay dividends, buy back shares, or invest heavily in growth. The fund’s yield is modest but steady, and capital appreciation is often the larger return driver.

Risks exist—they are structural, not operational. A company can have a durable moat and still face real dangers. Regulatory action can erode the moat: antitrust law, data-privacy rules, content moderation mandates, or pricing regulation can all narrow a company’s advantages and profit margins. Technology disruption is another threat—a monopoly in, say, search engines or online commerce could be undermined by a new technology or business model that the incumbent fumbles. And macro shocks matter: a deep recession, even one that hits only the fund’s sector, can compress valuations and cause losses, regardless of how wide the moat is.

Concentration risk is real. A fund holding only 30 to 50 stocks, all in the same theme (wide-moat dominance), carries significant concentration risk. If the investment thesis falters—if the market stops rewarding monopoly-like companies with premium valuations—or if a few large holdings stumble, the impact concentrates sharply. This is not a “set and forget” fund for someone seeking broad, stable market exposure.

Valuation is a recurring issue. Because the fund holds companies with strong competitive positions and low capital intensity, the market often values them at elevated price-to-earnings multiples. That valuation premium reflects confidence in their durability, but it also means the fund is buying at higher prices than a value-oriented investor might prefer. If investor sentiment turns against quality and moat-driven strategies, those premium valuations can contract, and the fund’s value can decline even if the underlying companies remain profitable.

Expense ratio and liquidity. MPLY charges roughly 0.70 to 0.80 percent annually, moderate for an actively managed US equity fund. Holdings are published, and the fund trades on major exchanges with reasonable liquidity.

The research question. For any investor considering MPLY, the core question is whether the companies it holds truly have monopoly-like moats or whether they are merely strong competitors with good brands and scale. That distinction matters for long-term returns. Reading the fund’s commentary on each holding and thinking critically about whether the competitive position is defensible for a decade is essential due diligence.